🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Shares

Novo Nordisk steps up ad spend to keep weight-loss crown

Published 02/07/2024, 12:41
© Reuters Novo Nordisk steps up ad spend to keep weight-loss crown
NOVOb
-

Proactive Investors - Novo Nordisk (CSE:NOVOb) appears to be taking a no-holds-barred approach to becoming the number one weight-loss drugmaker in the US after it emerged that an ad for one of its key products was viewed nearly 2 billion times between June 3 and June 25, making it the third most-watched commercial during that period.

The Wall Street Journal, citing iSpot.tv, reported the Wegovy ad, titled 'Discover the Power', was shown 6,271 times and cost an estimated $42 million in national airtime.

This surge in advertising follows an FDA-approved update for Wegovy, broadening its usage to include cardiovascular benefits for obese or overweight individuals with heart disease.

Novo Nordisk (LON:0QIU) is reportedly ramping up production and shipments to meet the growing demand. The company faces competition from compounded versions of its drugs and potential generics.

Read more on Proactive Investors UK

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.